Steven O'Day

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  

Steven O’Day
Apr 3, 2025, 18:28 | Blog
Dr. Steven O'Day Discusses Innovations in Immunotherapy for Colorectal Cancer on "The Top Line" by Fierce Biotech - Agenus
Agenus shared on LinkedIn: "Tune in to 'The Top Line' by Fierce Biotech! Our Chief…
Mar 25, 2025, 08:22 | Blog
Steven O'Day on the latest innovations and the future of immunotherapy
Steven O’Day, Chief Medical Officer at Agenus, joined Chris Hayden in a recent episode of…
Mar 18, 2025, 06:28 | Blog
Agenus CMO about the latest innovations in CRC Care "The Top Line"
Agenus shared a post on LinkedIn: "Tune in to 'The Top Line' by Fierce Biotech! Our…
Feb 12, 2025, 07:20 | Blog
How new evaluation methods are helping to better capture the impact of immunotherapy - Agenus
Agenus posted on LinkedIn: "Our Chief Medical Officer Dr. Steven O'Day explains how new evaluation…
Jan 30, 2025, 04:40 | Insight
Breelyn Wilky: Promising outcomes for immune cold sarcomas with BOT/BAL
Breelyn Wilky, Director of Sarcoma Medical Oncology at University of Colorado Anschutz Medical Campus, shared…
Jan 29, 2025, 07:24 | Science
Justin Stebbing: Botensilimab Plus Balstilimab in Patients With Relapsed/Refractory Metastatic Sarcomas
Justin Stebbing, Professor of Biomedical Sciences at Anglia Ruskin University (ARU), shared his recent article on…
Jan 6, 2025, 14:59 | Insight
Breakthroughs in immunotherapy by Steven O’Day and Alexander Eggermont
Agenus shared a post on LinkedIn: "A little over a year ago, we launched our…
Oct 17, 2024, 09:15 | Blog
Looking forward to Dr. Steven O'Day’s Eureka Moment talk at STAT Summit - Agenus
Agenus shared on LinkedIn: "Agenus has arrived at the STAT Summit! We’re looking forward to…
Sep 27, 2024, 12:14 | Blog
Proud to sponsor this year’s STAT Summit - Agenus
Agenus shared on LinkedIn: "We’re proud to sponsor this year’s STAT Summit, focused on delivering…
Jul 19, 2024, 02:00 | Blog
I ask Agenus to consider Armenia as the first country to register the BOT/BAL combination: Gevorg Tamamyan
"~20% ORR and 90% alive at 6 months in comparison to ZERO! How many patients…
Jul 18, 2024, 15:20 | Drugs
Our commitment to seek all possible pathways to make BOT/BAL available to patients is unwavering: Steven O'Day, Agenus CMO
Agenus shared on LinkedIn: "Today, we announced the outcomes of our End-of-Phase 2 meeting and…
Jul 11, 2024, 13:16 | Blog
Steven O'Day about how immunotherapy stands apart from traditional chemotherapy - Agenus
Agenus shared a post on LinkedIn:  . "Did you know immunotherapy activates the body’s own…
Jun 28, 2024, 15:58 | Insight
Updates on BOT/BAL from ESMOGI24
ESMO GI 2024 is held in Munich, Germany, and online from June 26-29. Organized by…
Jun 28, 2024, 13:48 | Insight
Arndt Vogel: Neoadjuvant botensilimab + balstilimab in MSI and MSS CRC at ESMOGI24
Arndt Vogel shared on X: "Neoadjuvant botensilimab + balstilimab in MSI and MSS CRC at…
Jun 28, 2024, 13:41 | Insight
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Agenus shared on their X page: "New data from the NEST clinical trial was presented…
Jun 28, 2024, 13:15 | Insight
The clinical utility of liquid biopsies detecting ctDNA in guiding treatment for patients with mCRC - ESMO
ESMO (European Society for Medical Oncology) shared on LinkedIn: "Data from two presentations at ESMOGI24…
Jun 28, 2024, 13:09 | Insight
Vittorio Studiale: Impressive pathological response rate with neoadjuvant BOT/BAL in MSS CRC
Vittorio Studiale, Medical Oncology Resident at University Hospital of Pisa, shared on X: "Impressive pathological…
Jun 28, 2024, 13:00 | Insight
Cathy Eng: Agenus with very promising data in early MSI-s/MSI-H colon cancer
Cathy Eng shared on X/Twitter: "Bot/Bal immunotherapy in colon cancer NEST 1/2. Agenus with very…
Jun 18, 2024, 23:25 | Insight
The future of immuno-oncology discussion with Agenus at ESMO GI 2024
Agenus shared a post on LinkedIn: “Are you a physician attending ESMO GI 24? Join…
Jun 13, 2024, 23:58 | Insight
Steven O'Day shared the latest data and insights from our botensilimab programs - Agenus
Agenus shared on LinkedIn: "Yesterday, our Chief Medical Officer, Dr. Steven O'Day, joined clinical experts…
Jun 10, 2024, 16:17 | Blog
Steven O’Day will be presenting an update on botensilimab programs at Nature Conferences’s event - Agenus
Quoting Agenus on X: "Tomorrow, Dr. Steven O’Day will be speaking at Nature Conferences’ Cancer Immunotherapy…
Mar 31, 2024, 23:33 | Blog
Steven O'Day: Please take one lesson with you as Colorectal Cancer Awareness Month nears it ends - get screened!
Steven O'Day shared a post on LinkedIn: "Please take one lesson with you as Colorectal Cancer…
Mar 18, 2024, 15:36 | Blog
Steven O’Day: Don’t let Colorectal Cancer Awareness Month pass this year without engaging
Steven O’Day shared on LinkedIn: “Don’t let Colorectal Cancer Awareness Month pass this year without…
Mar 10, 2024, 16:44 | Blog
Steven O’Day: March is Colorectal Cancer Awareness Month—a time where I am reminded of the resilience and courage of those affected by this disease
Steven O’Day shared on LinkedIn: "March is Colorectal Cancer Awareness Month—a time where I am…
Mar 3, 2024, 05:48 | Blog
Check out the latest 'Ask the Expert' webinar hosted by Melanoma Research Foundation - Agenus
Agenus shared a post on LinkedIn: ''In case you missed it, check out the latest…
Feb 22, 2024, 17:59 | Blog
“The Immuno-Oncology Curve” with Dr. Steven O'Day – Guests are Dr. Joseph Grossman and Dr. Benny Johnson
Steven O'Day, the Chief Medical Officer of Agenus, shared on LinkedIn: "In the latest episode…
Jan 9, 2024, 09:37 | Blog
“The Immuno-Oncology Curve” with Dr. Steven O’Day – Guests are Alexa Morell, Marianne Pearson and Andrew Wortmann
Steven O’Day, the Chief Medical Officer of Agenus, shared on LinkedIn: "Happy New Year! I’m…
Nov 28, 2023, 16:14 | Blog
“The Immuno-Oncology Curve" with Dr. Steven O'Day - Guest is Alexander (Lex) Eggermont
Steven O'Day, the Chief Medical Officer of Agenus, shared on LinkedIn: "I’m excited to announce…
Nov 20, 2023, 10:30 | Insight
Steven O'Day: I am thrilled to announce the upcoming launch of “The Immuno-Oncology Curve”
Steven O'Day, the Chief Medical Officer of Agenus, shared on LinkedIn: "I am thrilled to…
Nov 19, 2023, 00:23 | Blog
Steven O'Day: We are looking for an experienced pharma medical director (MD) with experience in oncology and immunotherapy and BLA submissions to join our passionate team and exciting pipeline
Nov 3, 2023, 12:10 | Drugs
Steven O'Day shared their recent webinar presented by Endpoints News on “The Next I-O Revolution”
Steven O’Day, the Chief Medical Officer of Agenus, shared on LinkedIn: ''Did you catch our…
Nov 1, 2023, 18:54 | Societies
20 Posts Not To Miss From ESMO 2023 Congress
The Annual Congress of the European Society For Medical Oncology (ESMO) took place from October…
Oct 30, 2023, 19:47 | Opinion
Jeniece Waite: Agenus is hiring clinical scientists
Jeniece Waite, Senior Recruiting Manager at Agenus, shared a post on LinkedIn: "As a Clinical…
Oct 29, 2023, 03:34 | Drugs
Steven O'Day: The research we shared underscores BOT’s broad potential utility across multiple advanced solid tumors
Steven O'Day, the Chief Medical Officer of Agenus, shared on LinkedIn: "It was an exciting…
Oct 15, 2023, 19:05 | Blog
Steven O'Day: I am thrilled to be joining Dr. Benjamin Schlechter, Dr. Pashtoon Kasi, and Phuong Ly-Gallagher for an engaging discussion on “The Next I-O Revolution”.
Sep 25, 2023, 16:07 | Insight
Steven O'Day: Today is World Cancer Research Day, which is a good day for me to share three things.
Quoting Steven O'Day, the Chief Medical Officer at Agenus, on LinkedIn: "Today is World Cancer…
All: 36 Posts: 1 - 100
Special Coverage